Gene: IGBP1C
Official Full Name: IGBP1 family member Cprovided by HGNC
Gene Summary: Predicted to enable protein phosphatase 2A binding activity. Predicted to be involved in regulation of dephosphorylation. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16994 | IGBP1C Knockout cell line (HeLa) | Human | IGBP1C | 1:3~1:6 | Negative | Online Inquiry |
KO16995 | IGBP1C Knockout cell line (HCT 116) | Human | IGBP1C | 1:2~1:4 | Negative | Online Inquiry |
KO16996 | IGBP1C Knockout cell line (HEK293) | Human | IGBP1C | 1:3~1:6 | Negative | Online Inquiry |
KO16997 | IGBP1C Knockout cell line (A549) | Human | IGBP1C | 1:3~1:4 | Negative | Online Inquiry |
IGBP1C Gene Knockout Cell Lines are specifically engineered cellular models designed to facilitate the study of the IGBP1C gene's function in various biological contexts. These cell lines have been meticulously developed through advanced gene editing techniques, such as CRISPR-Cas9, to ensure the complete knockout of the IGBP1C gene, which encodes a protein implicated in signaling pathways that affect immune response and inflammation. By eliminating the expression of this gene, researchers can observe cellular behaviors and interactions that would be impossible in wild-type cells, thus shedding light on the role of IGBP1C in pathophysiological processes.
The primary function of the IGBP1C Gene Knockout Cell Lines lies in their ability to serve as a reliable platform for dissecting the molecular mechanisms associated with immune system modulation. The absence of IGBP1C disrupts specific signaling cascades, allowing scientists to elucidate downstream effects on gene expression, protein interactions, and cellular responses. These insights can drive innovations in therapeutic approaches for diseases where IGBP1C plays a crucial role, including autoimmune disorders and cancer.
In clinical and research settings, IGBP1C knockout models present invaluable applications for drug discovery, biomarker identification, and the development of targeted therapies. Their use extends to understanding disease mechanisms, paving the way for personalized medicine strategies. Compared to traditional methods that rely on pharmacological inhibitors or RNA interference, gene knockout approaches offer a more definitive method to investigate gene function by providing a complete absence of gene activity.
The unique selling points of our IGBP1C Gene Knockout Cell Lines include their high reliability, consistent reproducibility, and the comprehensive validation processes undergone to ensure the knockout's efficacy. This product aligns with our company's commitment to delivering high-quality, cutting-edge biological tools that empower researchers and clinicians alike. Our expertise in genetic engineering and product development positions us at the forefront of biotechnological innovations, making our offerings indispensable for advancing scientific knowledge and improving health outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.